Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway

被引:35
|
作者
Wang, Y [1 ]
Nagase, S [1 ]
Koyama, A [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2004年 / 10卷 / 01期
关键词
nitric oxide; IGF-1; VEGF; rat glomeruli; endothelial nitric oxide synthase; expression; phosphorylation; phosphatidylinositol; 3-kinase;
D O I
10.1016/j.niox.2004.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) is reported to be involved in the pathogenesis of renal hyperfiltration in the early stage of diabetic nephropathy. We set out to determine whether IGF-I and/or VEGF(165) directly stimulate NO production in rat glomeruli and whether the expression of NO synthase (NOS) isoforms as well as eNOS phosphorylation contribute to NO generation by IGF-I and VEGF. Long-term exposure to IGF-I and/or VEGF165 augments NO production through increased eNOS mRNA, protein expression and phosphatidylinositol 3-kinase (P13-K) signaling pathway plays a major role in this process; short-term exposure to IGF-I and/or VEGF165 activates eNOS activity via phosphorylation by a P13-K/Akt dependent pathway. Our data suggest the great possibility that increased endogenous IGF-I and VEGF may be responsible for the up-regulation of eNOS expression and NO production which contributes to glomerular hyperfiltration in early diabetic kidneys. IGF-I is a newly described growth factor that up-regulates eNOS expression and P13-K plays a major role in this process. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 7 条
  • [1] Stimulatory effect of IGF-I and VEGF on eNOS phosphorylation, eNOS expression and nitric oxide production in rat glomeruli and the involvement of P13-K/Akt pathway.
    Wang, Y
    Nagase, S
    Hirayama, A
    Oteki, T
    Ueda, A
    Koyama, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 127A - 127A
  • [2] Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury
    Bai, Jiannan
    Wang, Qingchao
    Qi, Jiaxin
    Yu, Hongqiang
    Wang, Cong
    Wang, Xiaowei
    Ren, Yanru
    Yang, Fude
    PHYTOMEDICINE, 2019, 63
  • [3] Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO)
    Li, Chun-Ying
    Wang, Liang-Xue
    Dong, Si-Si
    Hong, Ying
    Zhou, Xin-He
    Zheng, Wen-Wen
    Zheng, Chao
    MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2018, 24 : 1 - 9
  • [4] An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells
    Zhang, Qing-Hai
    Zu, Xu-Yu
    Cao, Ren-Xian
    Liu, Jiang-Hua
    Mo, Zhong-Cheng
    Zeng, Ying
    Li, Yuan-Bin
    Xiong, Sheng-Lin
    Liu, Xing
    Liao, Duan-Fang
    Yi, Guang-Hui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 420 (01) : 17 - 23
  • [5] Direct Current Electric Field Stimulates Nitric Oxide Production and Promotes NO-Dependent Angiogenesis: Involvement of the PI3K/Akt Signaling Pathway
    Wei, Xing
    Guan, Linbo
    Fan, Ping
    Liu, Xinghui
    Liu, Rui
    Liu, Yu
    Bai, Huai
    JOURNAL OF VASCULAR RESEARCH, 2020, 57 (04) : 195 - 205
  • [6] LOW-INTENSITY ULTRASOUND INCREASES THE ENDOTHELIAL NITRIC OXIDE SYNTHASE (eNOS) EXPRESSION OF ENDOTHELIAL CELLS POSSIBLY VIA THE PHOSPHATIDYLINOSITOL 3-KINASE/AKT/PROTEIN KINASE A SIGNALING PATHWAY
    Hsu, Shan-hui
    Huang, Tsung-Bin
    Wang, Kuan-Pu
    BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS, 2010, 22 (05): : 367 - 376
  • [7] Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis -: Involvement of phosphatidylinositol 3-kinase
    Castrillo, A
    Bodelón, OG
    Boscá, L
    DIABETES, 2000, 49 (02) : 209 - 217